comprehensive -WSS

comprehensive

author：knowledge 2025-09-30 00:38:25 - browse：545

European Medicines Agency Suffers Cyber Attack in Amsterdam — Paulo Amorim / VWPics via AP Images

LONDON — This week, European regulators are considering an appeal from Amylyx Pharmaceuticals after initially recommending against approving the company’s ALS treatment — the latest potential turning point for a drug that has seen its share of ups and downs with regulatory bodies.

In June, a European Medicines Agency committee issued a negative review of Amylyx’s drug, called Albrioza, and cast doubt on whether it had demonstrated effectiveness in its pivotal study. That would have almost certainly led to a rejection by regulators, but Amylyx requested what’s called a re-examination of the opinion. On Tuesday, the EMA held a meeting on the appeal, and a decision is expected in the coming weeks.

“There are patients who are dying and they really want access to the drug,” said Evy Reviers, the chairwoman of the European Organization for Professionals and Patients with ALS, whose father has the neurological disease.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Mississippi candidates for statewide offices square off in party primaries

WSS

5 ways to address the shortage of health care workers

NEJM study measures Covid brain fog, impact on IQ

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

Childhood vaccination ad campaign launches in the U.K.

'Vaccine

Illinois to ban advertising for guns allegedly marketed to kids and militants

explore

comprehensive

Wikipedia

BioMarin wins approval for gene therapy to treat hemophilia A

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

Medicare proposal to cover medical devices draws a mixed reaction

Color Health wants to make cancer screenings convenient

The cancer drug shortage isn’t new — and neither are the solutions

Neuroscience renaissance leads to new crop of psychiatric drugs

Virginia high school admissions case could be legal follow

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

Apple is now the first public company to be valued at $3 trillion

Israel demolishes home of alleged Palestinian attacker, fueling West Bank tensions

knowledge

The UK government moves asylum

Medicare isn't yet testing food as medicine

Color Health wants to make cancer screenings convenient

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

'Vaccine

Trump lawyer welcomes Pence testifying in Jan. 6 trial, won't say if Trump will too

hotspot

knowledge

hotspot

hotspot